These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28251638)

  • 1. The impact of introducing medical management on conservative and surgical management for early pregnancy miscarriage.
    Black KI; de Vries BS; Moses F; Pelosi M; Cong A; Ludlow J
    Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):93-98. PubMed ID: 28251638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
    Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of first trimester missed miscarriage: the efficacy and complication rate.
    Serdinšek T; Reljič M; Kovač V
    J Obstet Gynaecol; 2019 Jul; 39(5):647-651. PubMed ID: 30917727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
    Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of first trimester miscarriage according to ultrasonographic findings.
    Vejborg TS; Nilas L; Rørbye C
    Acta Obstet Gynecol Scand; 2007; 86(5):604-9. PubMed ID: 17464591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the management of early pregnancy loss.
    Henkel A; Shaw KA
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):419-424. PubMed ID: 30299321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
    Ehrnstén L; Altman D; Ljungblad A; Kopp Kallner H
    Acta Obstet Gynecol Scand; 2020 Apr; 99(4):488-493. PubMed ID: 31784973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage.
    Patua B; Dasgupta M; Bhattacharyya SK; Bhattacharya S; Hasan SH; Saha S
    Arch Gynecol Obstet; 2013 Dec; 288(6):1243-8. PubMed ID: 23708389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
    Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
    Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient versus inpatient intravaginal misoprostol for the treatment of first trimester incomplete miscarriage: a randomised controlled trial.
    Ng BK; Annamalai R; Lim PS; Aqmar Suraya S; Nur Azurah AG; Muhammad Abdul Jamil MY
    Arch Gynecol Obstet; 2015 Jan; 291(1):105-13. PubMed ID: 25078052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual misoprostol for management of empty sac or missed miscarriage: The first two years' experience at a metropolitan Australian hospital.
    Mcgee TM; Diplock H; Lucewicz A
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):414-9. PubMed ID: 27323689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.